Nplate 250 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCC0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,497
Award facts
- Contract value 100% obligated
- $20,497.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of NPLATE 250 micrograms vials. The award was issued on December 19, 2025, with an ultimate completion date of January 13, 2026, and utilizes no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy established to support the pharmaceutical supply needs of military healthcare facilities worldwide.
DMS Pharmaceutical Group operates as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, leveraging its small business status and established performance record to deliver diverse pharmaceutical products including specialty medications, biologics, vaccines, and medical consumables. The parent PPV-G GEN V contract, awarded November 13, 2025, with a $500 million ceiling and completion date of December 31, 2036, positions the company as one of multiple regional prime vendor contractors supporting military medical operations globally. The company's substantial federal contracting activity and comprehensive product portfolio demonstrate its capability to fulfill specialized pharmaceutical requirements across multiple therapeutic categories for the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FSCC0?
SPE2DR26FSCC0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FSCC0 worth?
The government has obligated $20,497 on SPE2DR26FSCC0.
Is contract SPE2DR26FSCC0 an order under another contract?
Yes. SPE2DR26FSCC0 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCC0 competed?
The extent of competition for SPE2DR26FSCC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award